176 related articles for article (PubMed ID: 33984442)
1. Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women.
Hadami K; Saby C; Dakka N; Collin G; Attaleb M; Khyatti M; Filali-Maltouf A; Morjani H; El Mzibri M
Gene; 2021 Jul; 791():145709. PubMed ID: 33984442
[TBL] [Abstract][Full Text] [Related]
2. Analysis of mutations in the E6 oncogene of human papillomavirus 16 in cervical cancer isolates from Moroccan women.
Qmichou Z; Khyatti M; Berraho M; Ennaji MM; Benbacer L; Nejjari C; Benjaafar N; Benider A; Attaleb M; El Mzibri M
BMC Infect Dis; 2013 Aug; 13():378. PubMed ID: 23953248
[TBL] [Abstract][Full Text] [Related]
3. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6.
Lichtig H; Algrisi M; Botzer LE; Abadi T; Verbitzky Y; Jackman A; Tommasino M; Zehbe I; Sherman L
Virology; 2006 Jun; 350(1):216-27. PubMed ID: 16519914
[TBL] [Abstract][Full Text] [Related]
4. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
[TBL] [Abstract][Full Text] [Related]
5. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
6. HPV16 E6 polymorphism and physical state of viral genome in relation to the risk of cervical cancer in women from the south of Poland.
Szostek S; Zawilinska B; Klimek M; Kosz-Vnenchak M
Acta Biochim Pol; 2017; 64(1):143-149. PubMed ID: 27801430
[TBL] [Abstract][Full Text] [Related]
7. Degradation of p53 by natural variants of the E6 protein of human papillomavirus type 16.
Yi JW; Jang M; Kim SJ; Kim SS; Rhee JE
Oncol Rep; 2013 Apr; 29(4):1617-22. PubMed ID: 23404471
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
9. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
10. HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.
Gokhale PS; Sonawani A; Idicula-Thomas S; Kerkar S; Tongaonkar H; Mania-Pramanik J
J Med Virol; 2014 Jun; 86(6):968-74. PubMed ID: 24610458
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in human papillomavirus and cervical cancer outcomes.
Rader JS; Tsaih SW; Fullin D; Murray MW; Iden M; Zimmermann MT; Flister MJ
Int J Cancer; 2019 May; 144(9):2206-2214. PubMed ID: 30515767
[TBL] [Abstract][Full Text] [Related]
12. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China.
Sun Z; Lu Z; Liu J; Wang G; Zhou W; Yang L; Liu C; Wang B; Ruan Q
BMC Cancer; 2013 Oct; 13():459. PubMed ID: 24099556
[TBL] [Abstract][Full Text] [Related]
14. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
15. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
16. Effect of HPV 16 E6 Oncoprotein Variants on the Alterations of the Proteome of C33A Cells.
Garibay-Cerdenares OL; Sánchez-Meza LV; Encarnación-Guevara S; Hernández-Ortíz M; Martínez-Batallar G; Torres-Rojas FI; Mendoza-Catalán MÁ; Moral-Hernández OD; Leyva-Vázquez MA; Illades-Aguiar B
Cancer Genomics Proteomics; 2021; 18(3):273-283. PubMed ID: 33893080
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 molecular variants in Guarani Indian women from Misiones, Argentina.
Tonon SA; Basiletti J; Badano I; Alonio LV; Villa LL; Teyssie AR; Picconi MA
Int J Infect Dis; 2007 Jan; 11(1):76-81. PubMed ID: 16859947
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
19. Activities of human papillomavirus 16 E6 natural variants in human keratinocytes.
Asadurian Y; Kurilin H; Lichtig H; Jackman A; Gonen P; Tommasino M; Zehbe I; Sherman L
J Med Virol; 2007 Nov; 79(11):1751-60. PubMed ID: 17854024
[TBL] [Abstract][Full Text] [Related]
20. Functional effects of sequence variations in the E6 and E2 genes of human papillomavirus 16 European and Asian variants.
Hang D; Gao L; Sun M; Liu Y; Ke Y
J Med Virol; 2014 Apr; 86(4):618-26. PubMed ID: 24150786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
